<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Dowdy CR</submitter><funding>NIA NIH HHS</funding><funding>NCI NIH HHS</funding><pagination>1048-57</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC2830828</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>19(6)</volume><pubmed_abstract>Runx1 is a key hematopoietic transcription factor required for definitive hematopoiesis and is a frequent target of leukemia-related chromosomal translocations. The resulting fusion proteins, while retaining DNA binding activity, display loss of subnuclear targeting and associated transactivation functions encoded by the C-terminus of the protein. To define the precise contribution of the Runx1 C-terminus in development and leukemia, we created a knock-in mouse with a C-terminal truncation by introducing a single nucleic acid substitution in the native Runx1 locus. This mutation (Runx1(Q307X)) models genetic lesions observed in patients with leukemia and myeloproliferative disorders. The Runx1(Q307X) homozygous mouse exhibits embryonic lethality at E12.5 due to central nervous system hemor</pubmed_abstract><journal>Human molecular genetics</journal><pubmed_title>Definitive hematopoiesis requires Runx1 C-terminal-mediated subnuclear targeting and transactivation.</pubmed_title><pmcid>PMC2830828</pmcid><funding_grant_id>P01 CA082834</funding_grant_id><funding_grant_id>R01 AG030228</funding_grant_id><pubmed_authors>Lian JB</pubmed_authors><pubmed_authors>Dowdy CR</pubmed_authors><pubmed_authors>Vradii D</pubmed_authors><pubmed_authors>Jones SN</pubmed_authors><pubmed_authors>Stein GS</pubmed_authors><pubmed_authors>Xie R</pubmed_authors><pubmed_authors>Li X</pubmed_authors><pubmed_authors>Stein JL</pubmed_authors><pubmed_authors>Zaidi SK</pubmed_authors><pubmed_authors>Hussain S</pubmed_authors><pubmed_authors>Frederick D</pubmed_authors><pubmed_authors>van Wijnen AJ</pubmed_authors><pubmed_authors>Javed A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Definitive hematopoiesis requires Runx1 C-terminal-mediated subnuclear targeting and transactivation.</name><description>Runx1 is a key hematopoietic transcription factor required for definitive hematopoiesis and is a frequent target of leukemia-related chromosomal translocations. The resulting fusion proteins, while retaining DNA binding activity, display loss of subnuclear targeting and associated transactivation functions encoded by the C-terminus of the protein. To define the precise contribution of the Runx1 C-terminus in development and leukemia, we created a knock-in mouse with a C-terminal truncation by introducing a single nucleic acid substitution in the native Runx1 locus. This mutation (Runx1(Q307X)) models genetic lesions observed in patients with leukemia and myeloproliferative disorders. The Runx1(Q307X) homozygous mouse exhibits embryonic lethality at E12.5 due to central nervous system hemor</description><dates><release>2010-01-01T00:00:00Z</release><publication>2010 Mar</publication><modification>2025-04-21T18:43:22.822Z</modification><creation>2019-03-27T00:28:59Z</creation></dates><accession>S-EPMC2830828</accession><cross_references><pubmed>20035012</pubmed><doi>10.1093/hmg/ddp568</doi></cross_references></HashMap>